Exclusive

Publication

Byline

US Patent Issued to ARCUTIS BIOTHERAPEUTICS on July 21 for "Method for reducing side effects from administration of phosphodiesterase-4 inhibitors" (Colorado Inventor)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,727, issued on July 21, was assigned to ARCUTIS BIOTHERAPEUTICS INC. (Westlake Village, Calif.). "Method for reducing side effects from adm... Read More


US Patent Issued to AMNEAL PHARMACEUTICALS on July 21 for "Anti-vertigo compound and pharmaceutical compositions thereof" (Indian Inventor)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,728, issued on July 21, was assigned to AMNEAL PHARMACEUTICALS LLC (Bridgewater, N.J.). "Anti-vertigo compound and pharmaceutical compositi... Read More


US Patent Issued to PHAROS IBIO on July 21 for "Use of 2,3,5-substituted thiophene compound for enhancement of radiotherapy" (South Korean Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,729, issued on July 21, was assigned to PHAROS IBIO Co. LTD. (Gyeonggi-Do, South Korea). "Use of 2,3,5-substituted thiophene compound for e... Read More


US Patent Issued to TANABE PHARMA on July 21 for "Pharmaceutical composition for keratosis and use thereof" (Japanese Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,730, issued on July 21, was assigned to TANABE PHARMA Corp. (Osaka, Japan). "Pharmaceutical composition for keratosis and use thereof" was ... Read More


US Patent Issued to INTRA-CELLULAR THERAPIES on July 21 for "Organic compounds" (California, New Jersey Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,731, issued on July 21, was assigned to INTRA-CELLULAR THERAPIES INC. (Bedminster, N.J.). "Organic compounds" was invented by Peng Li (New ... Read More


US Patent Issued to The Industry & Academic Cooperation in Chungnam National University (IAC) on July 21 for "Composition for improving, preventing or treating muscular disorders including sulfonamide-based compounds" (South Korean Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,732, issued on July 21, was assigned to The Industry & Academic Cooperation in Chungnam National University (IAC) (Daejeon, South Korea). "... Read More


US Patent Issued to BioVentures on July 21 for "Indole molecules and use thereof in the inhibition of DNA polymerases" (Arkansas Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,733, issued on July 21, was assigned to BioVentures LLC. "Indole molecules and use thereof in the inhibition of DNA polymerases" was invent... Read More


US Patent Issued to The University of Chicago on July 21 for "N6-methyladenosine regulators in uterine fibroids" (Illinois Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,734, issued on July 21, was assigned to The University of Chicago (Chicago). "N6-methyladenosine regulators in uterine fibroids" was invent... Read More


US Patent Issued to Foghorn Therapeutics on July 21 for "BAF complex modulating compounds" (Massachusetts Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,735, issued on July 21, was assigned to Foghorn Therapeutics Inc. (Watertown, Mass.). "BAF complex modulating compounds" was invented by Ne... Read More


US Patent Issued to AXSOME THERAPEUTICS on July 21 for "Pharmaceutical compositions comprising meloxicam" (New York Inventor)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,736, issued on July 21, was assigned to AXSOME THERAPEUTICS INC. (New York). "Pharmaceutical compositions comprising meloxicam" was invente... Read More